Interview: How 'Notcoin' Will Evolve After the NOT Token Launch Open Builders founder Sasha Plotvinov speaks with Decrypt's Sander Lutz at Token 2049 Dubai about how he envisions Notcoin's expansion ...

The Union Ministry of Environment, Forest and Climate Change (MoEFCC) has granted in-principle approval for the Rs 2,395 crore cable-stayed bridge connecting Versova and Madh Island, a move expected ...

The problem is that the government is not ready to evolve, the Supreme Court observed on Wednesday after the Centre said it may not be "very feasible" to give the option to death row convicts to ...

Heavy deleveraging across derivatives markets drags XRP lower before buyers defend the $2.40 zone, setting up a key support retest heading into Asia trading.

Two brothers who were told their grandmother's £2.65 million family farm would 'one day be yours' are embroiled in a bitter court battle after being cut out of her will. Grandmother Mary Stevens, who ...

A new study has found that women make up more than half of U.S. gamers and that 22% of American gamers are over the age of 65. For decades, unflattering stereotypes of gamers as lethargic young men ...

OpenAI’s new Sora 2 text-to-video model has opened a new can of worms, filling social media with more content of questionable quality. We’re seeing an increasing number of videos featuring deceased ...

As simple as pro wrestling can be at times, it's far from it. This is best exemplified by which wrestlers do or don't get over. While there are plenty of talents that can have great matches or even ...

A striking black, barrel-roofed home built for Jane’s Addiction frontman and Lollapalooza founder Perry Farrell in Venice, California, came to market last week asking $2.65 million. Designed by ...

Google’s AlphaEvolve is pushing the boundaries of artificial intelligence by making new mathematical discoveries. From solving complex equations to uncovering patterns, it’s changing how humans and ...

(CNN) — Tramadol, a potent synthetic opioid, has been widely used to treat moderate to severe pain, but a new study suggests that the medication’s potential risks outweigh its “limited” benefits for ...